Abstract

Objective To investigate the influence of probiotics assisted with routine antibiotic regimens on the short-term clinical efficacy, mucosal barrier function and inflammatory response of patients with bacterial peritonitis secondary to liver cirrhosis. Methods 60 patients with bacterial peritonitis secondary to liver cirrhosis were chosen, and they were randomly divided into two groups according to the digital table, each group in 30 cases.The control group received routine antibiotic regimens alone, and the observation group were given probiotics on the basis of the control group.The short-term clinical efficacy, the levels of DAO, D-Lac and ET before and after treatment of the two groups were compared. Results The short-term effective rates of the control group and observation group were 70.00%, 96.67%, respectively.The short-term effective rate of the observation group was significantly higher than that of control group(χ2=9.14, P<0.05). After treatment, the levels of DAO of the control group and observation group were (4.33±0.79)U/mL, (2.19±0.47)U/mL, respectively.The levels of D-Lac of the control group and observation group after treatment were (15.88±1.95)U/mL, (8.57±1.03)U/mL, respectively.The levels of DAO and D-Lac of the observation group after treatment were significantly lower than those of the control group and before treatment(t=2.78, 3.06; 3.44, 3.78, 3.61, 4.10, all P<0.05). The levels of ET of the control group and observation group after treatment were (0.09±0.02)EU/mL, (0.04±0.01)EU/mL, respectively.The level of ET of the observation group after treatment was significantly lower than that of the control group and before treatment(t=2.49, 3.01, 3.46, all P<0.05). Conclusion Probiotics assisted with routine antibiotic regimens in the treatment of patients with bacterial peritonitis secondary to liver cirrhosis can effectively relieve the symptoms and signs, improve the mucosal barrier function and is helpful to reduce the inflammatory response. Key words: Probiotics; Peritonitis; Cirrhosis; Anti-infective ageuts

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.